Table 3.
Estimations of outpatient care costs for children with and without adverse events during RICP
| Medical resources | Patients with AEs (n = 7) | Patients without AEs (n = 6) | Mean difference | p-value |
|---|---|---|---|---|
| Laboratory test, mean (SD) | $23.13 ($61.20) | $14.55 ($35.65) | $8.58 | 1.000a |
| Blood products, mean (SD) | $3.87 ($10.25) | $0.00 ($0.00) | $3.87 | 0.354a |
| Outpatient medical consultation, mean (SD) | $82.03 ($24.06) | $69.30 ($41.06) | $12.73 | 0.422a |
| Chemotherapy (RICP), mean (SD) | $4,893.91 ($1,630.34) | $2,788.57 ($1,315.28) | $2,105.34 | 0.032a |
| Total, mean (SD) | $5,002.95 ($1,589.53) | $2,872.42 ($1,340.27) | $2,130.53 | 0.032a |
SD Standard deviation, AEs Adverse events
aWilcoxon rank-sum test